ESR1 and breast cancer: Indeed, a recent study mapping global binding sites for 24 nuclear receptors in the ERα-positive MCF-7 breast cancer cell line [52] provides evidence for the coordinate binding of many NRs to target regions throughout the genome, as exemplified by PPARδ, which as our results show is widely expressed across breast cancer subtypes.